These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 728887)

  • 21. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H; Herrmann R; Youssef M
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse.
    Bareham CR; Griswold DE; Calabresi P
    Cancer Res; 1974 Mar; 34(3):571-5. PubMed ID: 4590921
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
    Fisher B; Rubin H; Saffer E; Wolmark N
    Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.
    Vanhoecke B; Bateman E; Mayo B; Vanlancker E; Stringer A; Thorpe D; Keefe D
    Exp Biol Med (Maywood); 2015 Jun; 240(6):725-41. PubMed ID: 25966981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preclinical and clinical studies of sequential therapy with methotrexate and 5 fluorouracil in breast cancer].
    Kitamura M; Tominaga T; Hayashi K; Takahashi I; Kosaki G
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2430-8. PubMed ID: 3572145
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in the content and composition of gangliosides of tumors as affected by chemotherapeutic agents].
    Kozlov AM; Novikov AM; Bassalyk LS; Sof'ina ZP
    Eksp Onkol; 1984; 6(5):62-6. PubMed ID: 6510346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
    Tannock IF
    Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
    Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy: the interaction of methotrexate and 5-fluorouracil.
    Tattersall MH; Jackson RC; Connors TA; Harrap KR
    Eur J Cancer (1965); 1973 Oct; 9(10):733-9. PubMed ID: 4529730
    [No Abstract]   [Full Text] [Related]  

  • 30. Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats.
    Berger M; Habs M; Schmähl D
    Int J Cancer; 1983 Aug; 32(2):231-6. PubMed ID: 6874141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1985 Sep; 45(9):4200-5. PubMed ID: 4028010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of [5-125I]iododeoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors.
    Mester J; DeGoeij K; Sluyser M
    Eur J Cancer; 1996 Aug; 32A(9):1603-8. PubMed ID: 8911125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible interactions between antiblastic agents and warfarin inducing prothrombin time abnormalities.
    Malacarne P; Maestri A
    Recenti Prog Med; 1996 Mar; 87(3):135. PubMed ID: 8650435
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour.
    von der Maase H
    Radiother Oncol; 1986 Sep; 7(1):47-68. PubMed ID: 2430317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of the concept of methotrexate plus 5-FU sequence-dependent "synergy": how good is the evidence?
    Browman GP
    Cancer Treat Rep; 1984 Mar; 68(3):465-9. PubMed ID: 6200218
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling.
    Mulder JH; Smink T; van Putten LM
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):831-7. PubMed ID: 6949765
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.
    Benz C; Tillis T; Tattelman E; Cadman E
    Cancer Res; 1982 May; 42(5):2081-6. PubMed ID: 6175406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement and inhibition of mammary tumor formation and growth by cytostatic drugs.
    Medina D; Shepherd F
    Cancer Res; 1977 Oct; 37(10):3571-7. PubMed ID: 908008
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of antifolates and folates on the antineoplastic action of fluoropyrimidines].
    Graczyk J
    Postepy Hig Med Dosw; 1992; 46(2):143-58. PubMed ID: 1470578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.